Loading...
TrendSpott

TrendSpott

TrendSpott
 
 
Novavax
12.54
+0.80%
 
Recommendation
NVAX Novavax
  Login
 
 
Last Price
 
Change
 
12.54
 
+0.80%
 
 

 
Sentiment
 
  Login to display
 
 

16.78

19.34

31.72

155.84

 
 
1m
3m
6m
1y
 

Summary

  Login to display Novavax (NVAX) recommendation from the last 90 days from financial news and social media.
 

Risk Analysis

TrendSpott

 Analysts lowered price target

TrendSpott

 Insider selling during the past 3 months

 
 

Risk Level

 
TrendSpott
 

Novavax (NVAX) has High Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 
Earnings ×
 

Earnings

NA
 
 
 
Rating ×
 

Rating

NA
 
 
Momentum ×
 

Momentum

2.55
 

TrendSpott

Price value has negative momentum

 
Activity ×
 

Activity

3.60
 

TrendSpott

Debt capital raise

TrendSpott

Insider selling during the past 3 months

 
Potential ×
 

Potential

1.00
 

TrendSpott

Analysts lowered price target

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
48%
NA
27%
0%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish but have mixed views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
48%
30%
Positive
Negative
16 out of 33
events present
10 out of 33
events present
 

 
Events Calendar
Click for more information
 
December
S
M
T
W
T
F
S
January
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Price Target Lowered
2 Weeks Ago
9.79
-4.77%
 
Capital Raise
2 Month Ago
11.03
-2.56%
 
Capital Raise
2 Month Ago
11.32
-34.30%
 
Insider Selling
2 Month Ago
17.23
+0.12%
 
Latest Events

novavax up on getting approval for its booster covid vaccine for adults in south korea. (rttnews) - shares of novavax inc. (nvax) are rising more than 5% wednesday morning after the company said its partner sk bioscience received expanded manufa

Nasdaq - Markets

Today

Activity

novavax covid vaccine gets approval as booster for adults in south korea.

Seeking Alpha Symbol - NVAX

Today

Activity

novavax: nuvaxovid approved in south korea as booster for active immunization to prevent covid-19. (rttnews) - novavax inc. (nvax) said its partner sk bioscience has received expanded manufacturing and marketing approval from the korean ministry

Nasdaq - Markets

Today

Activity

dont blame the bear market for this growth stocks jaw-dropping sell-off. the pandemic set off an intense race among pharmaceutical companies to produce effective vaccines against covid-19. pfizer and moderna proved to be the leaders. but other c

Nasdaq Symbol - NVAX

Thu Jan 12, 2023

Momentum

harmony biosciences down 15% after ceo leaves for novavax.

Seeking Alpha Symbol - HRMY

Mon Jan 9, 2023

Momentum

novavaxs stock rallies after the company names new ceo.

Yahoo Business Finance

Mon Jan 9, 2023

Activity
Momentum

novavax appoints john jacobs to succeed stanley erck as president and ceo. (rttnews) - biotechnology company novavax inc. (nvax) announced that john jacobs will succeed stanley erck as president and chief executive officer and a member of the bo

Nasdaq Symbol - NVAX

Mon Jan 9, 2023

Activity
Activity

novavaxs longtime ceo stanley erck to retire. novavax inc said on monday its longtime chief executive officer stanley erck would retire and be succeeded by industry veteran john jacobs at a time when the covid-19 vaccine maker looks to catch up

Nasdaq Symbol - HRMY

Mon Jan 9, 2023

Activity

novavax hires john jacobs as new ceo as stanley erck to retire stock rises ~9%.

Seeking Alpha Symbol - NVAX

Mon Jan 9, 2023

Activity
Momentum

analyzing novavaxs short interest. ) short percent of float has fallen 4.15% since its last report. the company recently reported that it has

Benzinga - trading-ideas

Tue Jan 3, 2023

Activity

novavax pt lowered to $110 at h.c. wainwright.

Investing.com - News

Tue Jan 3, 2023

Potential

: novavax launches phase 2 trial for covid-flu combination vaccine candidate. this is a real-time headline. these are breaking news delivered the minute it happens delivered ticker-tape style. visit www.marketwatch.com or the e page for more information a

MarketWatch Real Time Headlines

Fri Dec 30, 2022

Activity

novavax kickstarts phase 2 trial for covid-19-flu combo stand-alone flu vaccine candidates. ) has initiated a phase 2 trial for its covid-19-influenza combination (cic) and

Benzinga - news

Fri Dec 30, 2022

Activity

novavax stock rises as vaccine maker secures $250m in stock debt offerings.

Yahoo Business Finance

Thu Dec 29, 2022

Momentum

better recovery story buy: teladoc vs. novavax. the bear market weighed on stocks in general this year. even some of the healthiest companies. but some stocks actually fell for a particular reason: they disappointed investors. theyve dropped to

Nasdaq Symbol - USAK

Wed Dec 28, 2022

Momentum

novavax updates plans for stock and debt offerings as its share price continues sinking.

Yahoo Business Finance

Fri Dec 16, 2022

Momentum

novavax prices $65m stock offering and $150m debt offering.

Seeking Alpha Symbol - NVAX

Fri Dec 16, 2022

Activity

guardant health novavax and some other big stocks moving lower in todays pre-market session. United States stock futures traded lower this morning. here are some big stocks recording losses in today&rsquo.s; pre-market trading session. ) dropped 33.1% t

Benzinga - small-cap

Fri Dec 16, 2022

Momentum

novavax sheds 34% day after announcing public stock offering supply agreement change.

Seeking Alpha Symbol - NVAX

Thu Dec 15, 2022

Activity

novavax tumbles on cut to uk covid vaccine-supply deal capital raising.

Yahoo Business Finance

Thu Dec 15, 2022

Activity
Momentum

novavax slips after announcing public offering of $125 mln common stock. (rttnews) - novavax inc. (nvax) shares are sliding more than 19 percent on thursday morning trade after announcing $125 million public offering of common stock.

Nasdaq Symbol - NVAX

Thu Dec 15, 2022

Activity
Momentum

novavax tesla western digital and some other big stocks moving lower in todays pre-market session. United States stock futures traded lower this morning. here are some big stocks recording losses in today&rsquo.s; pre-market trading session. ) shares fe

Benzinga - markets

Thu Dec 15, 2022

Activity

novavax stock sinks after proposed $125 million share sale convertible debt offering.

Yahoo Business Finance

Wed Dec 14, 2022

Activity
Activity
Momentum

novavax (nvax) cancels covid jab supply deal with gavi. novavax nvax announced that it sent a written notice to gavi alliance on nov 18 to terminate the advance purchase agreement (apa) entered between the two organizations last year f

Nasdaq Symbol - BNTX

Wed Nov 23, 2022

Activity

novavax says omicron shot shows strong immune response as second booster. vaccine maker novavax inc said on tuesday its covid-19 shot retooled against the omicron ba.1 variant showed a strong immune response as the fourth dose and met the main goal of str

Nasdaq Symbol - DNAA

Tue Nov 8, 2022

Activity

 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss
 

Receive our daily NVAX alerts

Enter your email to receive daily alerts

SECURITY POWERED BY

secure
guaranteed
 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
TrendSpott

TrendSpott

Get the pulse of the market

 
TrendSpott

TrendSpott

NVAX Novavax

Last Price
12.54
Change
+0.80%
Recommendation
  Login to display
 
 

Recently Viewed

 

NVAX

Novavax

 
 
 

Most Trending

 
 
 

Summary

  Login to display Novavax (NVAX) recommendation from the last 90 days from financial news and social media.

 
 
16.78
19.34
31.72
155.84
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Risk Analysis

TrendSpott

 Analysts lowered price target

TrendSpott

 Insider selling during the past 3 months

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
NA
27%
0%
On Track
On Track
On Track
 
48%
30%
Positive
Negative
16 out of 33
events present
10 out of 33
events present
 

Street Opinion

Street view is bullish but have mixed views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 
Earnings ×
 

Earnings

NA
 
 
 
Rating ×
 

Rating

NA
 
 
Momentum ×
 

Momentum

2.55
 

TrendSpott

Price value has negative momentum

 
Activity ×
 

Activity

3.60
 

TrendSpott

Debt capital raise

TrendSpott

Insider selling during the past 3 months

 
Potential ×
 

Potential

1.00
 

TrendSpott

Analysts lowered price target

 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Events Calendar
Hover on calendar for more information
 
December
 
S
M
T
W
T
F
S
 
 
 
January
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Price Target Lowered
2 Weeks Ago
9.79
-4.77%
 
Capital Raise
2 Month Ago
11.03
-2.56%
 
Capital Raise
2 Month Ago
11.32
-34.30%
 
Insider Selling
2 Month Ago
17.23
+0.12%
 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss

 

Receive our daily NVAX Alerts

Enter your email to receive daily alerts

 

SECURITY POWERED BY

TrendSpott
TrendSpott
 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines